(Q48738614)

15 February 2018

title

Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

4 December 2022

0 references

0 references

C. F. Saller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829974

4 December 2022

L. D. Kreamer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829974

4 December 2022

language of work or name

English

0 references

publication date

1 April 1991

1 reference

15 February 2018

19 April 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1829974

full work available at URL

4 December 2022

https://api.elsevier.com/content/article/PII:000689939191487L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

https://api.elsevier.com/content/article/PII:000689939191487L?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

4 December 2022

1 reference

15 February 2018

volume

546

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

235-240

1 reference

15 February 2018

Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Effect of L-DOPA on glucose oxidation and incorporation into glycogen in discrete brain regions of the rat.

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Intensive insulin shock therapy--a five-year survey.

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Enzymatic microdetermination of glycogen

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Potentiation of amphetamine-induced arousal by starvation

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Anorectic effect of lisuride and other ergot derivatives in the rat

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Brain 3-methyoxytyramine varies inversely with blood glucose in decapitated rats

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Sucrose sham-feeding in the rat after administration of the selective dopamine D2 receptor agonist N-0437, d-amphetamine or cocaine.

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Neuropharmacological studies on the neuroleptic potential of domperidone (R33812)

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Conjugated HVA increase in rat urine after insulin-induced hypoglycemia: involvement of central dopaminergic structures but not of adrenal medulla

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Comparative study of chlorpromazine and insulin coma in therapy of psychosis

4 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Carbohydrate and lymphoid studies in schizophrenia

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

N-0434, a very potent and specific new D-2 dopamine receptor agonist

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

The quantitative enzymic determination of animal liver glycogen

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dietary modulation of oral amphetamine intake in rats

4 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Selective DA2 versus DA1 antagonist activity of domperidone in the periphery

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dopamine receptor binding is increased in diabetic rats.

4 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia

4 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Striatal dopamine release is altered by glucose and insulin during push-pull perfusion of the rat's caudate nucleus

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Further analysis of the resistance of the diabetic rat to d-amphetamine

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

The levels of labile intermediary metabolites in mouse brain following rapid tissue fixation with microwave irradiation

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Insulin-mediated effects of glucose on dopamine metabolism.

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dietary correlates of hyperactive behavior in children

4 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase

4 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dopaminergic activity is reduced in diabetic rats.

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons

4 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Glucose potentiates haloperidol-induced catalepsy

4 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high-performance liquid chromatography with electrochemical detection

4 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)

4 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Effect of insulin on central catecholamines

4 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Antipsychotic drug doses and neuroleptic/dopamine receptors

4 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Behavioural role of dopamine D1 receptors in the reserpine-treated mouse

4 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Two dopamine receptors: biochemistry, physiology and pharmacology

4 December 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions

4 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats

4 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.

4 December 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned rats.

4 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Cognitive processes in normal and hyperactive children and their response to amphetamine treatment.

4 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Effect of glucose on amphetamine-induced motor behavior.

4 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patients

4 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)91487-L

4 December 2022

Identifiers

1 reference

15 February 2018

release_g3sivt5cvvap5j7jbehrsc4u34

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g3sivt5cvvap5j7jbehrsc4u34

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 February 2018